Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - Euronext Paris - Matif - FR0013419876 - Common Stock - Currency: EUR

4.68  -0.1 (-2.09%)

Fundamental Rating

6

ALVAP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 50 industry peers in the Specialty Retail industry. ALVAP has only an average score on both its financial health and profitability. ALVAP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

ALVAP had positive earnings in the past year.
ALVAP had positive earnings in each of the past 5 years.
ALVAP had negative operating cash flow in 4 of the past 5 years.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

1.2 Ratios

ALVAP has a Return On Assets of 11.93%. This is amongst the best in the industry. ALVAP outperforms 90.00% of its industry peers.
ALVAP has a better Return On Equity (19.68%) than 86.00% of its industry peers.
ALVAP has a Return On Invested Capital of 17.26%. This is amongst the best in the industry. ALVAP outperforms 90.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALVAP is above the industry average of 10.42%.
The last Return On Invested Capital (17.26%) for ALVAP is above the 3 year average (14.54%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROIC 17.26%
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

The Profit Margin of ALVAP (3.16%) is better than 70.00% of its industry peers.
In the last couple of years the Profit Margin of ALVAP has declined.
ALVAP has a Operating Margin of 4.84%. This is in the better half of the industry: ALVAP outperforms 68.00% of its industry peers.
In the last couple of years the Operating Margin of ALVAP has declined.
Looking at the Gross Margin, with a value of 22.53%, ALVAP is doing worse than 72.00% of the companies in the same industry.
ALVAP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 5 10 15 20

More info and screens

6

2. Health

2.1 Basic Checks

ALVAP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALVAP has more shares outstanding than it did 1 year ago.
ALVAP has a worse debt/assets ratio than last year.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ALVAP has an Altman-Z score of 6.37. This indicates that ALVAP is financially healthy and has little risk of bankruptcy at the moment.
ALVAP's Altman-Z score of 6.37 is amongst the best of the industry. ALVAP outperforms 94.00% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ALVAP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.26, ALVAP is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 6.37
ROIC/WACC2.35
WACC7.34%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

A Current Ratio of 3.49 indicates that ALVAP has no problem at all paying its short term obligations.
ALVAP has a Current ratio of 3.49. This is amongst the best in the industry. ALVAP outperforms 94.00% of its industry peers.
A Quick Ratio of 1.89 indicates that ALVAP should not have too much problems paying its short term obligations.
ALVAP has a better Quick ratio (1.89) than 86.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.49
Quick Ratio 1.89
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

ALVAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.14%, which is quite good.
Measured over the past years, ALVAP shows a very strong growth in Earnings Per Share. The EPS has been growing by 28.22% on average per year.
The Revenue has grown by 53.66% in the past year. This is a very strong growth!
The Revenue has been growing by 40.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%

3.2 Future

The Earnings Per Share is expected to grow by 4.97% on average over the next years.
The Revenue is expected to grow by 2.38% on average over the next years.
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.88 indicates a rather cheap valuation of ALVAP.
ALVAP's Price/Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 98.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.87. ALVAP is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.35, which indicates a rather cheap valuation of ALVAP.
ALVAP's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALVAP is cheaper than 94.00% of the companies in the same industry.
ALVAP's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 4.88
Fwd PE 5.35
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALVAP is valued cheaper than 92.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.64
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.14%, ALVAP has a reasonable but not impressive dividend return.
ALVAP's Dividend Yield is a higher than the industry average which is at 5.11.
Compared to an average S&P500 Dividend Yield of 2.46, ALVAP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.14%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 0.05 0.1

5.3 Sustainability

DPN/A
EPS Next 2Y1.2%
EPS Next 3Y4.97%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 2M -2M 4M

More info and screens

KUMULUS VAPE

EPA:ALVAP (4/28/2025, 7:00:00 PM)

4.68

-0.1 (-2.09%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap14.37M
Analysts86
Price Target8.82 (88.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.14%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.81%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-10%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.1%
Valuation
Industry RankSector Rank
PE 4.88
Fwd PE 5.35
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.29
EV/EBITDA 2.64
EPS(TTM)0.96
EY20.51%
EPS(NY)0.88
Fwd EY18.71%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.2
BVpS4.84
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.93%
ROE 19.68%
ROCE 23.81%
ROIC 17.26%
ROICexc 24.45%
ROICexgc 33.91%
OM 4.84%
PM (TTM) 3.16%
GM 22.53%
FCFM N/A
ROA(3y)10.22%
ROA(5y)8.85%
ROE(3y)15.46%
ROE(5y)14.08%
ROIC(3y)14.54%
ROIC(5y)14.31%
ROICexc(3y)19.15%
ROICexc(5y)21.12%
ROICexgc(3y)22.01%
ROICexgc(5y)23.52%
ROCE(3y)20.08%
ROCE(5y)19.87%
ROICexcg growth 3Y-11.77%
ROICexcg growth 5YN/A
ROICexc growth 3Y-20.68%
ROICexc growth 5YN/A
OM growth 3Y-6.99%
OM growth 5YN/A
PM growth 3Y-6.57%
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover3.78
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA 0.76
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.49
Quick Ratio 1.89
Altman-Z 6.37
F-ScoreN/A
WACC7.34%
ROIC/WACC2.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.14%
EPS 3Y28.22%
EPS 5YN/A
EPS Q2Q%-18.21%
EPS Next Y-2.41%
EPS Next 2Y1.2%
EPS Next 3Y4.97%
EPS Next 5YN/A
Revenue 1Y (TTM)53.66%
Revenue growth 3Y40.66%
Revenue growth 5YN/A
Sales Q2Q%2.01%
Revenue Next Year1.16%
Revenue Next 2Y1.36%
Revenue Next 3Y2.38%
Revenue Next 5YN/A
EBIT growth 1Y22.47%
EBIT growth 3Y30.83%
EBIT growth 5YN/A
EBIT Next Year6.77%
EBIT Next 3Y6.35%
EBIT Next 5YN/A
FCF growth 1Y299.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y413.64%
OCF growth 3YN/A
OCF growth 5YN/A